ABOUT US TECHNOLOGY SERVICES CONTACT US

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

WELCOME

Novus Biologicals Drug Discovery Screening Services specializes in the development and commercialization of proprietary reporter cell lines that provide the most advanced system available for screening Treg, TH17, TLR, STAT3 and inflammatory pathway mediators.  New and unique LUCporterTM stable reporter cell lines include promoters for IL-17A, RORg, RORg(t), FOXP3, IL-8, TLR3/IFNb, STAT3, AP-1, CXCL2 and the oncogenes Her-2 and elF4e as targets driving Renilla Luciferase reporter gene expression.

NEWS

07.11.13
Th17, Treg, IFN, TLR, NF-kB Reporter Cell Lines for Drug Discovery Screening

09.27.12
Novus Biologicals adds Visionary Pharmaceuticals' Th17 modulator VPR-66 to Research Market

SEE MORE
 
 
© NOVUS BIOLOGICALS. All Rights Reserved.